.

Recent News

Circassia abandons allergy programme after trial failure

British biotech Circassia has announced the death of its allergy programme following a second key trial failure, choosing to focus all of its efforts on its respiratory business instead.

British

Original Link...


Tags: medical, MEDICINE, pharmaceuticals
0 Volde
Report        

Read On: